A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name Journavx ...
EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its ...